Antibiotic Resistance and Typhoid

被引:89
|
作者
Dyson, Zoe A. [1 ]
Klemm, Elizabeth J. [1 ,2 ]
Palmer, Sophie [1 ]
Dougan, Gordon [1 ,2 ]
机构
[1] Univ Cambridge, Dept Med, Cambridge, England
[2] Wellcome Sanger Inst, Wellcome Genome Campus, Cambridge, England
基金
比尔及梅琳达.盖茨基金会; 英国惠康基金;
关键词
multiple drug resistance; MDR; S; Typhi; H58; typhoid; ENTERICA SEROVAR TYPHI; SALMONELLA-TYPHI; DRUG-RESISTANCE; EPIDEMIC; VIETNAM;
D O I
10.1093/cid/ciy1111
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Multiple drug (antibiotic) resistance (MDR) has become a major threat to the treatment of typhoid and other infectious diseases. Since the 1970s, this threat has increased in Salmonella enterica serovar Typhi, driven in part by the emergence of successful genetic clades, such as haplotype H58, associated with the MDR phenotype. H58 S. Typhi can express multiple antibiotic resistance determinants while retaining the ability to efficiently transmit and persist within the human population. The recent identification of extensively drug resistant S. Typhi only highlights the dangers of ignoring this threat. Here we discuss the evolution of the S. Typhi MDR phenotype and consider options for management. Typhoid remains a major global health challenge with antibiotic resistance emerging as a serious threat to treatment and control. The spread of antibiotic resistance in Salmonella Typhi, the cause of typhoid, is linked to a successful specialist clade known as H58.
引用
收藏
页码:S165 / S170
页数:6
相关论文
共 50 条